Under construction – not a live service
Sign in
Taking people in SwitzerlandNo phase

Registry of Adults Treated for Cardiogenic Shock at a Basel Hospital

Collects health data on adults with cardiogenic shock, a sudden severe heart failure.

Key facts

Who runs it
University Hospital, Basel, Switzerland
Where
Basel, SwitzerlandSee the site
Trial code
Registry title
BEAT-SHOCK Registry
Status
Recruiting
People taking part
8,000 people, planned
Started
1 Oct 2025
Expected to end
1 Oct 2035
Type of study
Observational
Treatments tested
  • no internvention
Record updated
11 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The registry is looking for adults with cardiogenic shock (the heart cannot pump enough blood) at University Hospital Basel, either on admission or developing during the hospital stay.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Cardiogenic shock with poor blood flow to the organs caused by a heart problem. Usually systolic blood pressure stays under 90 mmHg for at least 30 minutes, or medicines or mechanical heart support are needed. Signs of poor blood flow include raised lactate (arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l) and at least 1 of: cold or clammy limbs, altered mental status, reduced urine output, or signs of fluid overload or congestion. People with normal blood pressure can join if they show clear signs of poor blood flow and heart dysfunction, and other causes are ruled out.
Biomarker or test result
Raised lactate in the blood: arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l.

Main reasons for not taking part

  • Under 18 years of age
  • Patient or legal representative refuses informed consent

The registry criteria, word for word

Show all 14 criteriaShow less

Who cannot take part

  • Age <18 years
  • Refusal to provide informed consent by the patient or their legally authorized representative

Other criteria

  • Patients admitted with cardiogenic shock to the University hospital Basel (diagnosis at the time of admission) or development of cardiogenic shock during the hospital stay
  • Age ≥18 years
  • Provision of written ICF
  • Clinical diagnosis of cardiogenic shock
  • impaired organ perfusion due to primary cardiac dysfunction,
  • persistent systolic blood pressure (SBP) <90 mmHg for ≥30 minutes, or the need for vasopressors, inotropes, or mechanical circulatory support (MCS) to maintain adequate perfusion and
  • evidence of systemic hypoperfusion with arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l and ≥1 of the following:
  • Cold or clammy extremities
  • Altered mental status
  • Reduced urine output
  • Signs of volume overload or congestion (on clinical exam, imaging, or invasive monitoring)
  • Patients with normotensive cardiogenic shock (SBP ≥90 mmHg without vasopressors or MCS) may also be included if clear signs of hypoperfusion (arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l) and cardiac dysfunction are present and alternative causes are excluded

Where in Switzerland

  • University Hospital BaselBasel, SwitzerlandContact: Jasper Boeddinghaus, PD Dr. med.Taking people

About the trial

What the trial wants to find out

This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.

Treatments tested

  • no internvention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
BEAT-SHOCK (Basel Evaluation of Acute Therapy in Cardiogenic SHOCK) Registry
Plain-language title
Registry of Adults Treated for Cardiogenic Shock at a Basel HospitalGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
11 June 2026